SCIENTIFIC BREAKTHROUGH OPENS NEW FRONTIER IN THE FIGHT AGAINST ORAL CANCER
October 3, 2026
Researchers from NIT Rourkela and IISER Berhampur develop a cotarnine-derived compound that could pave the way for new approaches to oral cancer treatment.
Researchers from the National Institute of Technology (NIT) Rourkela and the Indian Institute of Science Education and Research (IISER) Berhampur have made progress in oral cancer research by developing a chemical derivative of cotarnine, a naturally occurring alkaloid, with potential therapeutic applications.
The research focuses on modifying cotarnine to develop a compound that could help target cancer cells and offer a possible new direction for oral cancer therapy. The development highlights the growing role of interdisciplinary scientific research in India, particularly in the fields of medicinal chemistry, biotechnology and cancer therapeutics.
Oral cancer remains a significant public health challenge in India, where tobacco consumption, including chewing tobacco, and other risk factors contribute to a substantial disease burden. Existing treatment approaches include surgery, radiotherapy and chemotherapy, depending on the type and stage of the disease. However, treatment-related complications, adverse effects and the risk of recurrence continue to drive the search for alternative therapeutic agents.
The research team's approach involves the chemical modification of cotarnine to investigate its potential anticancer properties. Such derivatives may offer opportunities to study how specific compounds interact with cancer cells and whether they can inhibit tumour growth while limiting damage to healthy tissues.
The findings represent a research-stage development rather than an established cancer treatment. Further investigations, including detailed safety assessments, preclinical studies and clinical trials, would be necessary to determine whether the compound could eventually be used in patients.
The work underscores the contribution of Indian research institutions to the development of potential therapeutic molecules and offers another avenue for scientific investigation into more targeted approaches to cancer treatment.
